100 related articles for article (PubMed ID: 10630850)
1. Nuclear matrix protein levels in burn patients with multiple organ dysfunction syndrome.
Yamada Y; Endo S; Nakae H; Kamei Y; Taniguchi S; Ishikura H; Tanaka T; Taki K; Inada K
Burns; 1999 Dec; 25(8):705-8. PubMed ID: 10630850
[TBL] [Abstract][Full Text] [Related]
2. Nuclear matrix protein, tumor necrosis factor-alpha, and nitrite/nitrate levels in patients with multiple organ dysfunction syndrome.
Yamada Y; Endo S; Kasai T; Koike S; Takakuwa T; Inoue Y; Niimi M; Endo Y; Wakabayashi G; Inada K
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):92-104. PubMed ID: 9644723
[TBL] [Abstract][Full Text] [Related]
3. Nuclear matrix protein (NMP) levels in patients with acute pancreatitis.
Endo S; Inada K; Inoue Y; Yamada Y; Fujino Y; Miura M; Baba E; Sato N; Wakabayashi G; Katsuya H; Sato S
J Med; 2000; 31(5-6):320-6. PubMed ID: 11508325
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and outcomes of multiple organ dysfunction syndrome among severe-burn patients.
Nguyen LN; Nguyen TG
Burns; 2009 Nov; 35(7):937-41. PubMed ID: 19553020
[TBL] [Abstract][Full Text] [Related]
5. Plasma tumor necrosis factor-alpha, its soluble receptors and interleukin-1beta levels in critically burned patients.
Zhang B; Huang YH; Chen Y; Yang Y; Hao ZL; Xie SL
Burns; 1998 Nov; 24(7):599-603. PubMed ID: 9882056
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of type II phospholipase A2 and nitrite/nitrate in patients with burns.
Yamada Y; Endo S; Kamei Y; Minato T; Yokoyama M; Taniguchi S; Nakae H; Inada K; Ogawa M
Burns; 1998 Sep; 24(6):513-7. PubMed ID: 9776089
[TBL] [Abstract][Full Text] [Related]
7. Reduction of plasma gelsolin levels correlates with development of multiple organ dysfunction syndrome and fatal outcome in burn patients.
Huang LF; Yao YM; Li JF; Dong N; Liu C; Yu Y; He LX; Sheng ZY
PLoS One; 2011; 6(11):e25748. PubMed ID: 22069445
[TBL] [Abstract][Full Text] [Related]
8. Association of proinflammatory molecules with apoptotic markers and survival in critically ill multiple organ dysfunction patients.
Papathanassoglou ED; Movnihan JA; Dafni O; Mantzoros CS; Ackerman MH
Biol Res Nurs; 2003 Oct; 5(2):129-41. PubMed ID: 14531217
[TBL] [Abstract][Full Text] [Related]
9. Study on delay two-phase multiple organ dysfunction syndrome.
Hu S; Sheng Z; Zhou B; Guo Z; Lu J; Xue L; Jin H; Sun X; Sun S; Li J; Lü Y
Chin Med J (Engl); 1998 Feb; 111(2):101-8. PubMed ID: 10374366
[TBL] [Abstract][Full Text] [Related]
10. Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome.
Delogu G; Famularo G; Amati F; Signore L; Antonucci A; Trinchieri V; Di Marzio L; Cifone MG
Crit Care Med; 1999 Nov; 27(11):2413-7. PubMed ID: 10579257
[TBL] [Abstract][Full Text] [Related]
11. [Change in serum levels of soluble Fas and soluble FasL in patients with multiple organ dysfunction syndrome].
Fu Y; Xiao QM; Wang T; Chen XH; Ai YH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):691-4. PubMed ID: 17092425
[TBL] [Abstract][Full Text] [Related]
12. Soluble Fas and soluble FasL in multiple organ dysfunction syndrome complicating diffuse peritonitis.
Kitamura M; Endo S; Sato N; Yaegashi Y; Suxzuki Y; Kojika N; Wakabayashi G
Res Commun Mol Pathol Pharmacol; 2004; 115-116():235-42. PubMed ID: 17564320
[TBL] [Abstract][Full Text] [Related]
13. [The predictive value of serum neopterin for multiple organ dysfunction syndrome in extensively burned patients].
Yao Y; Sheng Z; Chen J
Zhonghua Shao Shang Za Zhi; 2001 Jun; 17(3):142-5. PubMed ID: 11876928
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide (NO) production correlates with renal insufficiency and multiple organ dysfunction syndrome in severe sepsis.
Groeneveld PH; Kwappenberg KM; Langermans JA; Nibbering PH; Curtis L
Intensive Care Med; 1996 Nov; 22(11):1197-202. PubMed ID: 9120113
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Early Onset Multiple Organ Dysfunction in Major Burn Patients with Ventilator Support: Experience from A Mass Casualty Explosion.
Feng JY; Chien JY; Kao KC; Tsai CL; Hung FM; Lin FM; Hu HC; Huang KL; Yu CJ; Yang KY
Sci Rep; 2018 Jul; 8(1):10939. PubMed ID: 30026512
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis.
Haasper C; Kalmbach M; Dikos GD; Meller R; Müller C; Krettek C; Hildebrand F; Frink M
Technol Health Care; 2010; 18(2):89-100. PubMed ID: 20495248
[TBL] [Abstract][Full Text] [Related]
17. Vena-venous hemofiltration in treating severe injury-induced multiple organ dysfunction syndrome.
Fang Y; Zong HL; Zhang L; Wang ZH; Sun LM; Zhang RF
J Biol Regul Homeost Agents; 2016; 30(2):477-84. PubMed ID: 27358135
[TBL] [Abstract][Full Text] [Related]
18. [Effect of continuous renal replacement therapy started at different time on patients with multiple organ dysfunction syndrome].
Yao LQ; Jin ZC; Ji MS; Xia CY; Yu ZX; Liu J; Hu XL; Yan J
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1663-7. PubMed ID: 21914312
[TBL] [Abstract][Full Text] [Related]
19. [The expression and clinical implication of advanced oxidized protein products in patients with multiple organ dysfunction syndrome].
Xiong Y; Tang H; Li X; Liang YB; Liao XX; Zhan H; Jing XL; Li YJ; Ma ZF
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Sep; 20(9):542-5. PubMed ID: 18786315
[TBL] [Abstract][Full Text] [Related]
20. [Multi-center clinical study on the diagnostic criteria for multiple organ dysfunction syndrome with illness severity score system].
Zhang SW; Wang C; Yin CH; Wang H; Wang BE
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jun; 16(6):328-32. PubMed ID: 15182441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
